Latest Breaking News On - Tamaraa seymour - Page 1 : comparemela.com

SAN DIEGO, May 4, 2021 SAN DIEGO, May 4, 2021 /PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ( Kintara or the Company ), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the appointment of Tamara A. Seymour to the Company s Board of Directors replacing John Liatos, who will continue in his role as Kintara s Senior Vice President of Business Development. We are delighted to welcome Tamara to the Board of Directors as she brings exceptional healthcare sector experience as an accomplished financial and operational executive, commented Saiid Zarrabian, Kintara s President and Chief Executive Officer. Tamara s insights and perspectives will be a valuable addition to the Board and the entire Company as we continue to advance our platform assets VAL-083 and REM-001. We wish to thank John for his service to the Board and are excited to continue working with him as the Company s Senior VP of Business Development.

United statesSan diegoLa jollaJules abrahamJohn liatosTamaraa seymourNational cancer instituteCompany current reports on formCompany quarterly reports on formCompany annual report on formCompany seniorGeorgia state universityAudit committee of artelo biosciences incCompany board of directorsVital therapies incValdosta state university